Latest filing published 27 May 2021 for Panbela Therapeutics, Inc..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Paul W. Schaffer: trading record in brief
Paul W. Schaffer, listed as board member, appears in our data through filings on Panbela Therapeutics, Inc. shares, published by SEC (Form 4). We count 11 filings; the first trade dates from 24 June 2016 and the latest from 25 May 2021.
Every open-market trade on record is a purchase: 7 purchases worth €53k, and no sale. The amount is not disclosed for 5 filings. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 2 share grants.
On 27 May 2021 came the latest disclosure, a share grant in Panbela Therapeutics, Inc. The last purchase on record was published on 9 September 2020, which is 2,251 days ago. Typically, a trade is published a median of 4 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Paul W. Schaffer
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,316 shares0Common StockSEC:0001437749-21-013592:0
1 of 1 declaration